DASPERSE Trademark

Trademark Overview

On Wednesday, February 22, 2012, a trademark application was filed for DASPERSE with the United States Patent and Trademark Office. The USPTO has given the DASPERSE trademark a serial number of 85549228. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 5, 2015. This trademark is owned by Bristol-Myers Squibb Company. The DASPERSE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Product research and development; conducting clinical trials relating to pharmaceutical preparations for human use
dasperse

General Information

Serial Number85549228
Word MarkDASPERSE
Filing DateWednesday, February 22, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 5, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 10, 2012

Trademark Statements

Goods and ServicesProduct research and development; conducting clinical trials relating to pharmaceutical preparations for human use

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 29, 2012
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, October 5, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 5, 2015ABANDONMENT - NO USE STATEMENT FILED
Wednesday, March 11, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 10, 2015EXTENSION 5 GRANTED
Monday, March 2, 2015EXTENSION 5 FILED
Monday, March 2, 2015TEAS EXTENSION RECEIVED
Friday, September 5, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 4, 2014EXTENSION 4 GRANTED
Wednesday, September 3, 2014EXTENSION 4 FILED
Wednesday, September 3, 2014TEAS EXTENSION RECEIVED
Saturday, March 22, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 21, 2014EXTENSION 3 GRANTED
Tuesday, March 4, 2014EXTENSION 3 FILED
Tuesday, March 4, 2014TEAS EXTENSION RECEIVED
Wednesday, October 16, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 15, 2013EXTENSION 2 GRANTED
Wednesday, September 4, 2013EXTENSION 2 FILED
Friday, October 11, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, September 4, 2013TEAS EXTENSION RECEIVED
Tuesday, March 12, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, March 5, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 1, 2013EXTENSION 1 GRANTED
Friday, March 1, 2013EXTENSION 1 FILED
Friday, March 1, 2013TEAS EXTENSION RECEIVED
Tuesday, September 4, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 10, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 10, 2012PUBLISHED FOR OPPOSITION
Wednesday, June 20, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 5, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 4, 2012ASSIGNED TO EXAMINER
Wednesday, February 29, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, February 25, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

dasperse relating pharmaceutical preparations human trials clinical research development conducting product